Cortes, J. E., Jiang, Q., Wang, J., Weng, J., Zhu, H., Liu, X., Hochhaus, A., Kim, D.-W., Radich, J., Savona, M., Martin-Regueira, P., Sy, O. and Saglio, G. (2020) “Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to 3 months of imatinib therapy: final 5-year results from DASCERN”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2023.283428.